Committed under
Tega Therapeutics Inc
$1.7 Million committed in all years on record · 0.0% of the program
- Full records
- Tega Therapeutics Inc → everything they’re paid, across every program and agencyExtramural Research Programs in the Neurosciences and Neurological Disorders → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Extramural Research Programs in the Neurosciences and Neurological Disorders dollars committed to Tega Therapeutics Inc, per fiscal year.
* FY2026 is year-to-date — the fiscal year is still in progress, so its total is still filling in. The striped band and dashed line mark that provisional stretch.
Awards
The largest awards to Tega Therapeutics Inc under this program.
Title: New Clinical Biomarkers for GM1 Gamgliosidosis - Project Summary GM1 Gangliosidosis Is a Lysosomal Storage Disease in Which the Key H…
Nov 19, 2025$500,000
Title: Development and Validation of Therapy for GM1 Gangliosidosis - Project Summary GM1 Gangliosidosis Is Lysosomal Storage Disease in Whi…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants